Patient diagnosed with acromegaly and pituitary apoplexy after breast carcinoma treatment: challenges in diagnosis and management

HIGHLIGHTS

  • What: The article discusses the significance of immunohistochemical markers (like E-cadherin and Ki67) in predicting tumor behavior and response to treatment, which may guide personalized medical decisions.
  • Who: Ignacio Jiménez Hernando and Laura González Fernández from the Department of Endocrinology and Nutrition, Hospital General Universitario Gregorio Marañón, Madrid, Spain have published the article: Patient diagnosed with acromegaly and pituitary apoplexy after breast carcinoma treatment: challenges in diagnosis and management, in the Journal: (JOURNAL)

SUMMARY

    That elevated insulin-like growth factor type 1 (IGF-1) levels can . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?